ARCHIVES

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Clinton Budget For NIH “Disappointing,” AACR executive Director Says

May 7, 1993

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

November 18, 2011

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

Radiotherapy Provides Longer Life To Brain Cancer Patients

May 28, 2010

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’

May 3, 1991